GLP-1R activation in the habenula-IPN circuit In addition to the mesolimbic dopamine pathway, GLP-1 receptor agonists also impact the medial habenula-interpeduncular nucleus (MHb-IPN) pathway, a neural circuit that is equally significant but receives less attention
According to the FDA, more than 392 adverse events related to compounded semaglutide had been reported as of November 30, 2024
The trial result that drew comparisons to surgery In TRIUMPH-1, Lillys pivotal obesity trial with 2,339 participants, people on the highest dose lost an average of 28.3 percent of their body weight over 80 weeks
Unlike programs that focus only on prescriptions, RescueMD combines medication management with dietitian support, clinical oversight, and follow-up visits
This article was featured in the One Story to Read Today newsletter
At Apex MD: Clinical Support Meets Full Coaching Losing weight changes your physical frame, but maintaining it requires an energetic shift in how you live, eat, and move